VOLITIONRX LTD — Director's Dealing 2021

Nov 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-11-16-05:00

Reporting Person: Butera Salvatore Thomas (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-16-05:00	Common Stock	P	10000	$4.02	Acquired	10000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7000	Direct
Common Stock	150000	Direct

Footnotes

F1: These shares of Common Stock are jointly owned by Dr. Butera and his spouse.

F2: These restricted stock units are subject to a 3-year vesting schedule, vesting as to 50,000 units on each of 05/01/22, 05/01/23 and 05/01/24, respectively. Upon vesting and settlement, Dr. Butera will receive a number of shares of common stock equal to the number of restricted stock units that have vested.